论文部分内容阅读
肾性贫血是慢性肾脏病的重要临床表现,是慢性肾脏病患者合并心血管并发症的独立危险因素,有效治疗肾性贫血是慢性肾脏病一体化治疗的重要组成部分。重组人促红细胞生成素(rHuEPO)是临床上治疗肾性贫血的主要药物,在我国临床应用已经
Renal anemia is an important clinical manifestation of chronic kidney disease and an independent risk factor for cardiovascular complications in patients with chronic kidney disease. Effective treatment of renal anemia is an important part of the integrated treatment of chronic kidney disease. Recombinant human erythropoietin (rHuEPO) is the clinical treatment of renal anemia, the main drug used in our country has been